The Patent Finder

Vitae Pharmaceuticals, Inc.

Also on record
Records under this name other than the patents Vitae Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 44 patents it holds.

Back to Vitae Pharmaceuticals, Inc.

PatentTitleStatus Expires Confidence
US 8,138,178Cyclic Inhibitors of 11BETA-HYDROXYSTEROID Dehydrogenase 1
Formerly held
In force
 · Medium confidence
In forceMedium confidence
US 8,680,093Cyclic Inhibitors of 11BETA-HYDROXYSTEROID Dehydrogenase 1
Formerly held
In force
 · Medium confidence
In forceMedium confidence
US 9,663,470Aryl- and Heteroarylcarbonyl Derivatives of Hexahydroindenopyridine and Octahydrobenzoquinoline
Formerly held
In force
 · High confidence
In forceHigh confidence
US 9,090,605Substituted 5-,6- and 7-Membered Heterocycles, Medicaments Containing Such Compounds, and Their Use
Formerly held
In force
 · High confidence
In forceHigh confidence
US 10,654,884Purine Derivatives as CD73 Inhibitors for the Treatment of Cancer
Formerly held
In force
 · High confidence
In forceHigh confidence
US 11,919,901Inhibitors of the Menin-Mll Interaction
Formerly held
In force
 · High confidence
In forceHigh confidence
US 10,188,618Treatment of Cancer with Specific RXR Agonists
Formerly held
Term ended
Term ended Oct 2, 2026 · Medium confidence
Term endedTerm ended Oct 2, 2026Medium confidence
US 10,596,133Treatment of cancer with specific RXR agonists
Formerly held
In force
Ended no later than Oct 2, 2026 · From the USPTO record
In forceEnded no later than Oct 2, 2026From the USPTO record
US 10,973,788Treatment of cancer with specific RXR agonists
Formerly held
In force
Ended no later than Oct 2, 2026 · From the USPTO record
In forceEnded no later than Oct 2, 2026From the USPTO record
US 10,047,085Dihydropyrrolopyridine Inhibitors of Ror-Gamma
Lapsed on the fee record
Ended Aug 14, 2026 · High confidence
Lapsed on the fee recordEnded Aug 14, 2026High confidence
10 of 50 patents shown.
Pro members see all 50.
Pro members: see all 50 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited